Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis

scientific article published on January 1, 1979

Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID421230

P2093author name stringW. G. Kramer
C. W. Driever
G. A. Frick
R. Ballentine
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectD-(-)-mannitolQ407646
P304page(s)13-16
P577publication date1979-01-01
P1433published inCancer Treatment ReportsQ27710285
P1476titleRenal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis
P478volume63

Reverse relations

cites work (P2860)
Q36355684A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.
Q46231923Acute and long-term nephrotoxicity of cis-platinum in man.
Q43712532Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment?
Q51609240Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseas
Q67600077Calcium blockers enhance cisplatin-induced nephrotoxicity in rats
Q70667286Cisplatin disposition in children and adolescents with cancer
Q92313119Citrus aurantium Ameliorates Cisplatin-Induced Nephrotoxicity
Q67552719Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice
Q69934312Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum
Q36424378Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer
Q50074885Pharmacokinetic-Pharmacodynamic Analysis of Cisplatin with Hydration and Mannitol Diuresis: The Contribution of Urine Cisplatin Concentration to Nephrotoxicity
Q39768346Pharmacokinetics of anticancer drugs in children
Q36322728Platinum antitumour agents: a review of (bio)analysis
Q36949303Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study.
Q70676378[Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)]

Search more.